Sensing of viral infections in c. Elegans
Active Project Grant Awarded Last action
- Award ID
- R21AI196715
- Recipient
-
The Washington University UEI L6NFUM28LQM5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $427,625
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 37% complete
- Place of performance
- St. Louis, MO 63110, USA
Award details come from USAspending.gov.
About this award
The National Institute of Allergy and Infectious Diseases awarded The Washington University $427,625 on February 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support basic research on viral infection sensing in C. elegans.
The funded research examines how the model organism C. elegans recognizes and responds to RNA virus infection, specifically Orsay virus (ORV), the only known natural virus of this nematode species. The project investigates the host genes required for viral recognition and the viral-derived molecular patterns sensed by C. elegans, with the goal of identifying novel viral recognition and signaling pathways that may be broadly conserved across species. The work addresses a significant gap in understanding how simple multicellular invertebrates mount antiviral responses, focusing on the role of DRH-1, a C. elegans helicase homologous to mammalian RIG-I and MDA5, in activating the intracellular pathogen response to ORV infection.
The Washington University's Office of Sponsored Research Services Division serves as the recipient and performs the work. Performance occurs in St. Louis, Missouri. The award period runs from February 2, 2026, through January 31, 2028. The assistance type is a Project Grant, classified as R21 funding intended to support exploratory and developmental research.
Description
- Abstract
- RNA viruses pose a threat to organisms ranging from bacteria to humans, and thus all hosts need to recognize and defend themselves from these foreign invaders. While some principles of RNA virus recognition have been defined, primarily in mammalian systems, there remains a significant GAP in knowledge as to how different hosts recognize the presence of an RNA virus. Much less is known about how simple metazoans, such as the model organism c. Elegans, recognize virus infection. Studies in c. Elegans have led to the discovery of multiple fundamental paradigms in biology, such as identification of caspase cell death pathways and RNA interference (rnai). The discovery over a decade ago of orsay virus (ORV), a positive strand RNA virus that is the first and only known natural virus of c. Elegans to date, opened the door to virus-host interaction studies in this simple, multicellular invertebrate model system. Defining the host genes required for recognizing an RNA virus and the viral derived molecules that are sensed by c. Elegans will provide novel insights into the evolution of self-versus-nonself discrimination. These studies could also lead to identification of novel viral recognition and signaling pathways that are broadly conserved. In mammals a family of cytoplasmic receptors that includes RIG- i and MDA5 senses the presence of intracellular RNA virus derived products. They then signal through additional proteins, such as mavs, to activate transcription factors, including IRF3, IRF7, and NF-KB to induce an antiviral transcriptional response. C. Elegans encodes DRH-1, a dicer related helicase that is homologous to RIG-i and MDA5, that is required for activation of the c. Elegans transcriptional response, termed the intracellular pathogen response (IPR), to ORV infection. However, since c. Elegans does not possess orthologs of mavs, IRF3, IRF7 or NF-KB, IT is not clear how the sensing of an RNA virus is transduced in c. Elegans and what genes are involved. The viral derived molecule(s) that are recognized in c. Elegans is also poorly defined. RIG-i binds viral dsrna with a 5' triphosphate while MDA5 binds longer dsrnas independent of the 5' terminus. In c. Elegans, replication of ORV from a plasmid-based replicon system is sufficient to activate the IPR implicating an ORV replication product as the trigger. In preliminary data, we demonstrated that non-replicating ORV dsrna produced by the endogenous c. Elegans transcription machinery is sufficient to activate the IPR in vivo. This implies that viral dsrna with 5' cap structure can be a trigger, providing the first evidence that DRH-1 maybe more similar to MDA5 than RIG-1. Thus, studies of DRH-1 may provide novel insights into the evolution and function of MDA5-like sensing proteins. Here, we will (1) define the host factors that recognize viral infection and are responsible for transducing that signal into a transcriptional response, and (2) determine the precise nature and characteristics of the viral ligand(s) that is recognized by c. Elegans.
Quick answers
Who received award R21AI196715?
R21AI196715 was awarded to The Washington University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 2, 2026.
How much is award R21AI196715 worth?
$427,625 has been obligated on R21AI196715.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award